These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 17552023)

  • 1. Hepatitis C virus proteins.
    Dubuisson J
    World J Gastroenterol; 2007 May; 13(17):2406-15. PubMed ID: 17552023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The amino-terminus of the hepatitis C virus (HCV) p7 viroporin and its cleavage from glycoprotein E2-p7 precursor determine specific infectivity and secretion levels of HCV particle types.
    Denolly S; Mialon C; Bourlet T; Amirache F; Penin F; Lindenbach B; Boson B; Cosset FL
    PLoS Pathog; 2017 Dec; 13(12):e1006774. PubMed ID: 29253880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of programmed cell death pathways by the hepatitis C virus.
    Aweya JJ; Tan YJ
    Front Biosci (Landmark Ed); 2011 Jan; 16(2):608-18. PubMed ID: 21196192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The pathogenesis of hepatitis C virus induced by viral proteins].
    Kohara K; Munakata T; Kohara M
    Nihon Rinsho; 2011 May; 69 Suppl 4():97-102. PubMed ID: 22096901
    [No Abstract]   [Full Text] [Related]  

  • 5. Processing and functions of Hepatitis C virus proteins.
    Suzuki R; Suzuki T; Ishii K; Matsuura Y; Miyamura T
    Intervirology; 1999; 42(2-3):145-52. PubMed ID: 10516468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HCV ARFP/F/core+1 protein: production and functional analysis of an unconventional viral product.
    Vassilaki N; Mavromara P
    IUBMB Life; 2009 Jul; 61(7):739-52. PubMed ID: 19548320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular accumulation of hepatitis C virus proteins in a human hepatoma cell line.
    Brazzoli M; Crotta S; Bianchi A; Bagnoli F; Monaghan P; Wileman T; Abrignani S; Merola M
    J Hepatol; 2007 Jan; 46(1):53-9. PubMed ID: 17107733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis C virus].
    Querenghi F; Zoulim F
    Rev Prat; 2000 May; 50(10):1060-5. PubMed ID: 10905089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Translation stimulation and shut-off by HCV and viral multiplication].
    Kato J; Shiratori Y; Kato N; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):85-8. PubMed ID: 15359769
    [No Abstract]   [Full Text] [Related]  

  • 10. Dynamic Interaction of Stress Granules, DDX3X, and IKK-α Mediates Multiple Functions in Hepatitis C Virus Infection.
    Pène V; Li Q; Sodroski C; Hsu CS; Liang TJ
    J Virol; 2015 May; 89(10):5462-77. PubMed ID: 25740981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-structural protein 4A of Hepatitis C virus accumulates on mitochondria and renders the cells prone to undergoing mitochondria-mediated apoptosis.
    Nomura-Takigawa Y; Nagano-Fujii M; Deng L; Kitazawa S; Ishido S; Sada K; Hotta H
    J Gen Virol; 2006 Jul; 87(Pt 7):1935-1945. PubMed ID: 16760395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatocarcinogenesis by HCV infection].
    Naganuma A; Nozaki A; Kato N
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():55-9. PubMed ID: 11762010
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation.
    Dolganiuc A; Kodys K; Kopasz A; Marshall C; Do T; Romics L; Mandrekar P; Zapp M; Szabo G
    J Immunol; 2003 Jun; 170(11):5615-24. PubMed ID: 12759441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.
    McGivern DR; Masaki T; Lovell W; Hamlett C; Saalau-Bethell S; Graham B
    J Virol; 2015 May; 89(10):5362-70. PubMed ID: 25740995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of HCV structural proteins impairs IFN-mediated antiviral response.
    Keskinen P; Melén K; Julkunen I
    Virology; 2002 Aug; 299(2):164-71. PubMed ID: 12202219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural biology of hepatitis C virus.
    Penin F; Dubuisson J; Rey FA; Moradpour D; Pawlotsky JM
    Hepatology; 2004 Jan; 39(1):5-19. PubMed ID: 14752815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulation of hepatitis C virus (HCV) internal ribosome-entry site-mediated translation by HCV replicons and nonstructural proteins.
    He Y; Yan W; Coito C; Li Y; Gale M; Katze MG
    J Gen Virol; 2003 Mar; 84(Pt 3):535-543. PubMed ID: 12604803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction.
    Barth H; Schnober EK; Zhang F; Linhardt RJ; Depla E; Boson B; Cosset FL; Patel AH; Blum HE; Baumert TF
    J Virol; 2006 Nov; 80(21):10579-90. PubMed ID: 16928753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daclatasvir Prevents Hepatitis C Virus Infectivity by Blocking Transfer of the Viral Genome to Assembly Sites.
    Boson B; Denolly S; Turlure F; Chamot C; Dreux M; Cosset FL
    Gastroenterology; 2017 Mar; 152(4):895-907.e14. PubMed ID: 27932311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reporter-based assay for identifying hepatitis C virus inhibitors based on subgenomic replicon cells.
    Lee JC; Chang CF; Chi YH; Hwang DR; Hsu JT
    J Virol Methods; 2004 Mar; 116(1):27-33. PubMed ID: 14715304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.